BF
Bryan Faust
Investment Partner - Bio + Health at Andreessen Horowitz
San Francisco, California
Overview
Bryan Faust is currently an Investment Partner at Andreessen Horowitz, specializing in investments in the Bio + Health sector. With a background in Biophysics and experience at renowned companies like AbbVie and Genentech, he brings a wealth of expertise to his role, focusing on Series A and Seed stage investments in sectors such as Consumer Health, BioTech, and Health IT in the San Francisco Bay Area.
Work Experience
Investment Partner - Bio + Health
2024 - Current
Investment Analyst - Bio + Health
2022 - 2024
Andreessen Horowitz is a stage-agnostic venture capital firm with assets under management across multiple funds.
PhD Candidate - Biophysics
2018 - 2022
Fellow
2022 - 2022
5AM Ventures is a venture capital firm that aims to finance seed and early-stage life sciences companies.
Scientist - Biophysics
2017 - 2018
AbbVie is a pharmaceutical company that discovers, develops, and markets medicines.
Raised $15,000,249,999.00.
Research Associate - Biophysics
2014 - 2017
Stemcentrx provides pharmaceutical services.
Raised $515,526,990.00 from Sequoia Capital, Artis Ventures (AV), Fidelity, Founders Fund, Silicon Valley Bank and Oakhouse Partners.
Research Associate
2014 - 2014
Genentech specializes in genetic testing and personalized medicine.
Manufacturing Associate
2013 - 2014
Fetal Stem Cell and Regenerative Medicine Intern
2012 - 2013
Research Assistant
2009 - 2011
Breastlink is a medical practice company providing breast cancer treatment, prevention, screening, and diagnosis.